Vertigo and Motion Sickness. Part I: Vestibular Anatomy and Physiology
Vertigo and Motion Sickness. Part I: Vestibular Anatomy and Physiology
Vertigo and Motion Sickness. Part I: Vestibular Anatomy and Physiology
Abstract
Control of the symptoms of vertigo and motion sickness vestibular nucleus. Secondary vestibular afferent fibers are
requires consideration of the neurophysiology of areas responsible for making connections with the contralateral
both intrinsic and extrinsic to the vestibular system propel: vestibular nuclei, oculomotor control areas, the cerebellum,
We review the essential anatomy and physiology of the and the spinal cord.
vestibular system and the associated vomiting reflex. The chief neurotransmitter in the vestibular nuclei is
believed to be the excitatory amino acid glutamate. Elec-
Introduction tron-microscope autoradiography demonstrates glutamate
Vertigo is often accompanied by visceral autonomic symp- uptake sites in the lateral and inferior vestibular nuclei of
toms, including pallor, diaphoresis, nausea , and vomiting. cats .The number of these sites is significantly decreased by
Vertigo is similar to motion sickness in that both can be previous sectioning of the vestibular nerve, indicating that
caused by vestibular stimulation that does not match an glutamate is involved in the transfer of signals from ves-
internal model of expected environmental stimuli. Indeed , tibular afferent neurons . 1.2 Glutamate actions are mediated
a functioning vestibular system is necessary for the per- by excitatory amino acid receptors. The four main families
ception of motion sickness.' For this reason, many of the of excitatory amino acid receptors are a-amino-3-hydroxy- .
same drugs are used to treat both conditions. Selection of 5-methyl-4-isoxazole propionic acid receptors (AMPA),
a particular type of drug therapy can be facilitated by an N-methyl-D-aspartate receptors (NMDA), metabotropic
understanding of the essential anatomy and physiology of glutamate receptors, and kainic acid receptors. AMPA,
the vestibular system and the associated vomiting reflex. NMDA, and metabotropic receptors have been found in
the vestibular nuclei . 1.3 Glutamate appears to act primarily
Vestibular pathways on AMPA-type receptors in the vestibular nuclei.'
The receptor cells for vestibular stimuli are the hair cells of Acetylcholine has been identified in primary vestibular
the vestibular labyrinth. Type I hair cells are flask-shaped afferents of the vestibul ar nuclei.' In cat studie s involving
and connected to a single large afferent nerve fiber. Type measurements of the field potential of the lateral vestibular
II cells are cylindrical, and they are innervated by a series nucleus, the application of acetylcholine produces the
of bouton -type nerve endings at their base. These sensory same response as does stimulation of the vestibular nerve.
cells are found in the cristae at the ampullated ends of the In addition, the response to stimulation of the vestibular
semicircular canals and in the maculae of the utricle and nerve is enhanced by inhibition of acetylcholinesterase
sacculus. Movement of the endolymph in the semicircular and blocked by the antimuscarinic drug scopolamine.l"
canals, and movement of the otoliths in the case of the Muscarinic receptors are acetylcholine-binding receptors
maculae, is translated by the hair cells into an electrical that have historically been demonstrated to be activated
impulse. This impulse is propagated by the afferent nerves by muscarine and blocked by atropine.
toward the vestibular nuclei. There are four vestibular nu- Knowledge of muscarinic receptor subtypes and their
clei: the superior vestibular nucleus, the lateral vestibular pharmacologic actions is increasing, and more effective
nucleus , the medial vestibular nucleus, and the descending anticholinergic medications with fewer side effects are in
development. There are now five known structural subtypes
of muscarinic receptors, designated m, through ms' The
From ENT Associates, John son City, Tenn . (Dr. Zajonc) , and the Depart- capitalized designations M" M 2, and M 3 represent phar-
ment of Otola ryngology-Head and Neck Surgery, Uni versity of macologic definitions, which are based on the actions of
Texas Southwestern Medical Center at Dallas (Dr. Roland) . various drugs that bind muscarinic receptors selectively. It
Reprint requests: Peter S. Roland, MD , Professor and Chairm an, De-
has been shown that the structural designations m, through
partment of Otolaryngology-Head and Neck Surgery, University
of Texas Southwestern Medic al Center, 5323 Harry Hines Blvd., m3 cOlTelate with the pharmacologic definitions M, through
Dallas, TX 75390-9035. Phone : (2 14) 648-3102; fax: (214) 648- M 3, respectively. In situ hybridization studies of rat brain
2246 ; e-mail : peter.roland @utsouthwestern.edu have demonstrated a unique distribution of muscarinic
receptor subtypes. P The m l receptors are abundant in Neurokinin type I (NK I) receptors have been found in
the cerebral cortex, striatum, and hippocampus. The m z some vestibular afferents.' NK, receptors bind substance P,
recep tors are very rare in brain tissue; they are found in which is a neuroactive peptide. Substance P is thought to
significant quantities only in the media l septum and pons be involved in many actions throug hout the body, includ-
and in lesser amoun ts in the thalamus.The distribution of m3 ing the transmission of painful stimuli, but its role in the
recep tors is simi lar to that of m, receptors, but m3receptors vestibular system is unclear at this time ."
are also found in severa l thalamic nuclei and brainstem Other receptors found in the vestibular nuclei include D,
nuclei. The m4 receptors are found in the cortex , striatum , dopaminergic receptors, 5-HT IAand 5-HT2 (seroto ninergic)
and hippocampus, and the ms receptors are fou nd in very receptors, and (J,z - and PI-adrenergic receptors (table). 4.13.14
low levels in the hippocampus and some brains tem nuclei. Norepinephrine, which binds adrenergic receptors, has
Bovine brain studies have also revea led that muscar inic been reported to block neuronal firing in the medial ves-
receptors are found in the vestibular nuclei." Localization tibular nucleus while it stimulates neurons in the lateral
of receptor subtypes to specific areas of the brain allows vestibular nucleus.' :"
for the possibility of designi ng drugs that have a more
specific action. The cerebellu m
Another regulatory substance in the vestibular nuclei The cerebe llum is believed to functio n as a regu lator of
is histamine. H I' Hz, and H3 recep tors are present in the movement and posture by comparing movement intention
medial vestibular nucleus.t'? Field-potential recordings with movement performance and regulating the actions
demonstra te that the HI antagonist diphenhydramine of descending motor neurons . Information gathered on
decreases firing of polysynaptic pathways in the lateral movement intention is called internal feedback. Sensory
vestibular nucleus.':" information about motor performance is called external
Other inhibitory actions in the vestibular nuclei are me- feedback. Vestibular stim uli, represen ting spatial orienta -
diated by y-aminobutyric acid (GABA). Two subclasses tion, are also regarded as externa lfeedback. The cerebellum
of GABA rece ptors- GABA A and GABA B-are found compares internal and external feedback signals in order
in the vestibular nuclei . GABA A recep tors are bound by to regulate performance. The cerebellum is also believed
benzodiazepines for agonist effec ts. GABA B receptors to contain a conceptual internal model that reflects norma l
bind baclofen for agonist effects. Neuro ns from the con- sensory congruities for a given movement or posture.
tralateral vesti bular nuclei and Purki nje fibers from the When the comparison of the internal and external feedback
cerebellum are believed to exert their inhibitory effects signals does not fall within the parameters of this internal
via this GA BAergic system.' model, a sensory mismatch is said to exist. These sensory
Area Vestibular
Receptor postrema PCRFINTS Cerebellum nuclei Cortex
AMPA/ NMDA + + + + +
Muscarinic + + + + +
Histaminic H2 H3 H1 H lI H2 , H3 H lI H2 , H3
Dopaminergic D2 , D3 D2 , D3 , D4 D3 D2 DlI D2 , D4 1 o,
a· Adrenergic + + a2 a2 a2
Key: p eRF = par vicellular reticular forma tion; NTS = nucleus tractus solitarius; AMPA = a-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid; NMDA = N-methyl -D-aspartate; GABA = y-aminobutyric acid.
Organizational model 12. Ot suka M, Yanagisa wa M. Does substa nce P act as a pain tran smit -
The currently understood model for the production of ter ? Trend s Pharmac ol Sci 1987;8:50 6-10 .
13. de Waele C, Muhleth aler M, Vidal PP. Neurochemi stry of the central
vertigo or motion sickness includes a system in which ves tibular path way s. Brain Res Brain Res Rev 1995 ;20:24-46.
information is gath ered from vestibular, visua l, proprio- 14. Za nni M , G iardino L, Tosc hi L, et al. Distribution of neu rotr an s-
ceptive, and cortical activity (figure). This information is mitt ers, neuropeptides, and recept o rs in the vest ibu lar nucle i
co mplex of the rat: An immunocy toc hem ica l, in situ hyb ridizat ion
then compared with an internal model of expected input
and quantit ati ve recept or autoradiog raphic study. Brain Res Bull
congruity. Detection of a stimulus mism atch promotes the 1995; 36:443-5 2.
symptoms associated with vertigo and motion sickness. 15. Kirsten EB, Sh arm a I N. Cha racter istics and response differen ces
Thi s comparator also serves to promote habit uation to new to iontopho retica lly applied norep inep hrine, D-amphetamin e, and
ace tylcho line on neur ons in the med ial and lateral ves tibular nuc lei
environmental stimuli or compensation for erroneous input
of the cat. Bra in Res 1976; 112:77- 90.
caused by disease. 16. Kand el ER , Schw art z 1H, 1essell TM , eds. Princip les of Neural
It is interesting that some medications that are excellent Scien ce. 3rd ed. New York: Elsevier, 1991.
antiemetics do not prevent vertigo or motion sickness. 17. Rob inson DA . Ad aptive gain control of ves tibulooc ular reflex by
the cereb ellu m. J Neu rophy siol 1976 ;39:954- 69.
One such medication, ondansetron, is often used for the 18. Singleton GT. Rel at ion ship s of the cer ebe llar nodulus to vest ibular
prevention of chemotherapy-induced nau sea . It acts on function : A study of the effects of nodul ectomy on hab ituation.
5-HT3 receptors in the area postrema. Activity in this Laryngo scop e 1967 ;77 : 1579- 16 19.
location would not necessarily prevent stimul ation of the 19. Tyler DB, Bard P. Motion sickness . Physiol Re v 1949;29:3 11-69.
20. Ito M. Recen t advances in ce rebellar ph ysiol ogy and patho logy.
vestibular nuclei from ultimatelycausing nausea and vomit- Adv Neurol 1978 ;2 1:59 -84 .
ing. However, patients who are particularly susceptible to 21 . L1inas R, Walton K, Hillman DE , Sotelo C. Inferior oliv e: Its role
motion sickness also demonstrate increased responses to in motor learning. Science 1975; 190: 1230-1.
other vomiting center stimuli.This may provide a rat ionale 22. Borison HL , Wang SC . Fun ctional locali zation ofcentral coordinat-
ing mech ani sm for eme sis in cat. J Ne urophysiol 1949; 12:305- 13.
for the use of general antiemetics in vertigo associated 23 . Hasega wa S, Taked a N, Morita M, et al. Vestibul ar, central and
with nausea.v-" gas tral trigger ing of emes is: A study on ind ividu al susceptibility
The role of medications in treating ver tigo and mot ion in rats. Act a Otol aryn gol 1992 ; 112:927-31 .
24 . Baloh RW. Dizzin ess, Hearing Loss, and Tinn itus. Phil adelphi a:
sickness will be reviewed in part II of this article in an
EA. Davis, 1998.
upcoming issue. 25 . Palermo-Net o 1. Dop amin ergic sys tems. Dop am inergic receptors.
Psychi atr Clin North Am 199 7;20:705 -21 .
References 26. Missale C, Nash SR, Robin son SW, et al. Dopamine receptors:
I. Crampton GH , ed. Motion and Space Sickn ess. Boca Raton, Fla.: From struc ture to funct ion . Phy siol Rev 1998 ;78: 189-225.
CRC Pre ss, 1990 . 27. 1aarsm a D, Rui grok T1, Caffe R, et al. Ch ol ine rgic innervat ion and
2. Raym ond 1, Nieou llon A, Dememes D, San s A. Ev ide nce fo r receptors in the ce rebellum. Pro g Brain Res 1997 ; 114:67- 96 .
glutamate as a neur otransmitter in the cat vestibular nerv e : Ra- 28 . Russo-Neu stadtA, Cotm an CWAdrenergic receptors inAl zheime r's
dio autographi c and biochemical studies. Exp Brain Res 1984 ;56 : di sease bra in: Sel ecti ve incre ases in the cerebella of asare ssive
523- 31. pat ient s. 1 Neurosci 1997 ; 17:5573-80 . ee
3. Gallagher JP. An electrophysiological investi gati on of the rat me- 29 . Pompeiano O. Norad renergic influenc es on the cerebe llar corte x:
dial ves tibular nucl eu s in vitro. In: Correi a M1, Perachio AA, eds . Effects on ves tibular refle xes und er basic and adaptive conditio ns.
Contemporary Sen sory Neurobiology. (Proceedings of the th ird Otolaryngo l Head Neck Surg 1998; 119 :93- 105 .
symposi um of the Galveston chapter of the Society for Neurosci- 30. Bongianni F, M utolo D, Carfi M, Pant aleo T. Area po strem a glu-
ence ; May 14-15 , 1984; Galveston, Tex.) Ne w York: Al an R. Li ss, tamate receptors medi ate resp irator y and gas tric resp onses in the
1985:293. rabbit. Neurorep ort 199 8;9:2057-62 .
4. Yates B1, Miller AD , LucotJB. Physiological basis and pharmacol- 3 1. Cumming P, Gjedd e A, Vincent S. Histamine H3 binding sites in
ogy of motion sickn ess: An update. Brain Res Bull 1998;47 :395- rat brain: Localizati on in the nucl eus of the so lita ry tract. Brain
406 . Res 1994 ;641 : 198-20 2.
5. Mat suoka I, Domino EE Cholinergic mechani sms in the cat ves - 32 . Q ian M, John son Ali, Kallstrom L, et al. Ch olecystokinin, dopamine
tibu lar sys tem. Ne uropharmacology 1975 ; 14:20 1- 10. D2 and N-m eth yl-D -asp artat e binding sites in the nucleus of the
6. Matsuoka I, Ito 1, Takahashi H, et al. Experim ental ves tibular so litary tract of the rat: Possibl e relati on ship to inge stive behavior.
ph armacology : A minireview with special referen ce to neuro acti ve Neu roscience 1997;77: 1077-89.
substances and ant ivertigodrugs.ActaOtolaryngo l Supp119 84 ;4I 9: 33 . Hyd e TM , Knabl e MB , Mu rray AM . Distribution of dop amine
62-70 . D I-D4 receptor subtypes in human dorsal vagal complex. Synap se
7. Weiner DM , Br ann MR .Thed istribution of a dopam ine D2 receptor 1996 ;24:224-32.
mRNA in rat bra in. FEBS Lett 1989;253:207- 13. 34. Yoshi kawa T, Yosh ida N, Hosoki K. Involvement of dop amin e D3
8. Hu lme EC , Birdsall N1, Buckley NJ. Muscarini c recept or subty pes . recept ors in the area postrem a in R( +)-7-0 H-DPAT-induced emes is
Annu Re v Pharm acol ToxicoI1 990;30:633-73 . in the ferret. Eur 1 PharmacoI 1996 ;301 :143-9.
9. Ped igo NW, 1r, Bri zzee KR. Muscarinic cholinergic receptors in 35. Paakkari I, Karppanen H, Paakk ari P. S ite and mod e of action of
area po strema and brainstem areas regulating emesis. Brain Res clonidin e in the central nervous syste m. Acta Med Sc and Supp!
Bull 1985 ; 14:169-77. 1976;60 2: 106-9 .
10. Lew is MR . Histam ine HI and H2 mech ani sm s may modu late 36. Avoli M , H wa G, Lou vel 1, et al. Fun ctional and ph arm acolo gical
motion sickness development. Aerospace Medic al Association prop ertie s of GABA-me diated inhibitio n in the human neocortex.
Ab stract 1987 :AIO . Can J Physiol Pharm acol 1997;75:526 -34 .
II. Takatan i T, Ito J, Matsuoka I, et al. Effe cts of diph enhydramine 37 . Yabe T, de Wael e C, Serafin M, et al. Medial vestibular nucleu s in
iontophoretically applied onto neurons in the medial and lateral the g uinea -pig: Histaminergic rece ptors. II. An in vitro study. Exp
vestibular nuclei. Jpn J PharmacoI1 983 ;33:557-61. Brain Res 1993; 93 :249-58.